Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC |
DELANEY MARK ESVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 2,326 | $204.86 | $476,504.36 |
DisclosureSEC source: 0001022079-26-000030 · wk-form4_1772833481.xml · nonDerivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,864 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC |
DELANEY MARK ESVP & Chief Commercial Officer
|
GrantCommon Stock | 5,682 | $204.86 | $1,164,014.52 |
DisclosureSEC source: 0001022079-26-000030 · wk-form4_1772833481.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,190 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 3,354 | $204.86 | $687,100.44 |
DisclosureSEC source: 0001022079-26-000029 · wk-form4_1772833467.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,435 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantCommon Stock | 7,232 | $204.86 | $1,481,547.52 |
DisclosureSEC source: 0001022079-26-000029 · wk-form4_1772833467.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,789 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC |
Davis J. E.Director · CEO and President
|
Tax withholdingCommon Stock | 26,414 | $204.86 | $5,411,172.04 |
DisclosureSEC source: 0001022079-26-000028 · wk-form4_1772833455.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,423 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC |
Davis J. E.Director · CEO and President
|
GrantCommon Stock | 51,652 | $204.86 | $10,581,428.72 |
DisclosureSEC source: 0001022079-26-000028 · wk-form4_1772833455.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,837 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC |
Plewman PatrickSVP for Diagnostic Services
|
Tax withholdingCommon Stock | 2,827 | $204.86 | $579,139.22 |
DisclosureSEC source: 0001022079-26-000027 · wk-form4_1772833437.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,053 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC |
Plewman PatrickSVP for Diagnostic Services
|
GrantCommon Stock | 5,682 | $204.86 | $1,164,014.52 |
DisclosureSEC source: 0001022079-26-000027 · wk-form4_1772833437.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,880 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:43 UTC |
Deppe Michael JSVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 750 | $204.86 | $153,645.00 |
DisclosureSEC source: 0001022079-26-000026 · wk-form4_1772833419.xml · nonDerivative · entry 2 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,196 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:43 UTC |
Deppe Michael JSVP, Corp. Controller & CAO
|
GrantCommon Stock | 1,473 | $204.86 | $301,758.78 |
DisclosureSEC source: 0001022079-26-000026 · wk-form4_1772833419.xml · nonDerivative · entry 1 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,946 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:43 UTC |
KUPPUSAMY KARTHIKSVP, Clinical Solutions
|
SaleCommon Stock | 2,628 | $204.86 | $538,372.08 |
DisclosureSEC source: 0001022079-26-000025 · wk-form4_1772833398.xml · nonDerivative · entry 2 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,441 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:43 UTC |
KUPPUSAMY KARTHIKSVP, Clinical Solutions
|
GrantCommon Stock | 6,200 | $204.86 | $1,270,132.00 |
DisclosureSEC source: 0001022079-26-000025 · wk-form4_1772833398.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,069 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:39 UTC |
Doherty Catherine T.EVP, Regional Businesses
|
SaleCommon Stock | 632 | $207.73 | $131,285.36 |
DisclosureSEC source: 0001022079-26-000024 · wk-form4_1772660351.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,122 F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:38 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 526 | $207.73 | $109,265.98 |
DisclosureSEC source: 0001022079-26-000022 · wk-form4_1772660322.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,557 F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:38 UTC |
Plewman PatrickSVP for Diagnostic Services
|
SaleCommon Stock | 410 | $207.73 | $85,169.30 |
DisclosureSEC source: 0001022079-26-000020 · wk-form4_1772660286.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,198 F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:39 UTC |
SAMAD SAMExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 869 | $204.86 | $178,023.34 |
DisclosureSEC source: 0001022079-26-000023 · wk-form4_1772660338.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,041 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:39 UTC |
Doherty Catherine T.EVP, Regional Businesses
|
Tax withholdingCommon Stock | 648 | $204.86 | $132,749.28 |
DisclosureSEC source: 0001022079-26-000024 · wk-form4_1772660351.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,754 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:38 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 288 | $204.86 | $58,999.68 |
DisclosureSEC source: 0001022079-26-000022 · wk-form4_1772660322.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,083 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:38 UTC |
Davis J. E.Director · CEO and President
|
SaleCommon Stock | 10,000 | $212.52 | $2,125,200.00 |
DisclosureSEC source: 0001022079-26-000021 · wk-form4_1772660306.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,185 F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:38 UTC |
Davis J. E.Director · CEO and President
|
Tax withholdingCommon Stock | 2,968 | $204.86 | $608,024.48 |
DisclosureSEC source: 0001022079-26-000021 · wk-form4_1772660306.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,185 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:38 UTC |
Plewman PatrickSVP for Diagnostic Services
|
Tax withholdingCommon Stock | 230 | $204.86 | $47,117.80 |
DisclosureSEC source: 0001022079-26-000020 · wk-form4_1772660286.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,608 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:37 UTC |
DELANEY MARK ESVP & Chief Commercial Officer
|
Tax withholdingCommon Stock | 188 | $204.86 | $38,513.68 |
DisclosureSEC source: 0001022079-26-000018 · wk-form4_1772660249.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,508 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:37 UTC |
KUPPUSAMY KARTHIKSVP, Clinical Solutions
|
Tax withholdingCommon Stock | 205 | $204.86 | $41,996.30 |
DisclosureSEC source: 0001022079-26-000019 · wk-form4_1772660268.xml · nonDerivative · entry 1 KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,869 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:37 UTC |
Deppe Michael JSVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 88 | $204.86 | $18,027.68 |
DisclosureSEC source: 0001022079-26-000017 · wk-form4_1772660229.xml · nonDerivative · entry 1 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,473 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 22:13 UTC |
Plewman PatrickSVP for Diagnostic Services
|
SaleCommon Stock | 958 | $204.83 | $196,227.14 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · nonDerivative · entry 4 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,838 F3 · shares: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 22:12 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 1,111 | $204.83 | $227,566.13 |
DisclosureSEC source: 0001222679-26-000002 · wk-form4_1771625527.xml · nonDerivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,371 F3 · shares: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 22:11 UTC |
Doherty Catherine T.EVP, Regional Businesses
|
SaleCommon Stock | 1,433 | $204.83 | $293,521.39 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,402 F3 · shares: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:13 UTC |
Plewman PatrickSVP for Diagnostic Services
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 9,009 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · derivative · entry 5 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,009 Underlying: Common Stock · 9,009 shares Expires 2036-02-18 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:13 UTC |
Plewman PatrickSVP for Diagnostic Services
|
Tax withholdingCommon Stock | 293 | $206.99 | $60,648.07 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · nonDerivative · entry 3 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,796 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:13 UTC |
Plewman PatrickSVP for Diagnostic Services
|
Tax withholdingCommon Stock | 244 | $210.01 | $51,242.44 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · nonDerivative · entry 2 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,089 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:13 UTC |
Plewman PatrickSVP for Diagnostic Services
|
GrantCommon Stock | 1,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001497368-26-000002 · wk-form4_1771625587.xml · nonDerivative · entry 1 Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,333 F1 · security: Represents an award of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:12 UTC |
SAMAD SAMExecutive Vice President & CFO
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 18,303 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001694295-26-000002 · wk-form4_1771625556.xml · derivative · entry 5 SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,303 Underlying: Common Stock · 18,303 shares Expires 2036-02-18 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:12 UTC |
SAMAD SAMExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 1,010 | $206.99 | $209,059.90 |
DisclosureSEC source: 0001694295-26-000002 · wk-form4_1771625556.xml · nonDerivative · entry 3 SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,841 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:12 UTC |
SAMAD SAMExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 855 | $210.01 | $179,558.55 |
DisclosureSEC source: 0001694295-26-000002 · wk-form4_1771625556.xml · nonDerivative · entry 2 SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,851 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:12 UTC |
SAMAD SAMExecutive Vice President & CFO
|
GrantCommon Stock | 3,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001694295-26-000002 · wk-form4_1771625556.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,706 F1 · security: Represents an award of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:12 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 9,289 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001222679-26-000002 · wk-form4_1771625527.xml · derivative · entry 6 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,289 Underlying: Common Stock · 9,289 shares Expires 2036-02-18 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:12 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 347 | $206.99 | $71,825.53 |
DisclosureSEC source: 0001222679-26-000002 · wk-form4_1771625527.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,482 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:12 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 301 | $210.01 | $63,213.01 |
DisclosureSEC source: 0001222679-26-000002 · wk-form4_1771625527.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,829 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:12 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantCommon Stock | 2,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001222679-26-000002 · wk-form4_1771625527.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,130 F1 · security: Represents an award of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC |
Davis J. E.Director · CEO and President
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 73,225 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001599837-26-000002 · wk-form4_1771625504.xml · derivative · entry 4 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,225 Underlying: Common Stock · 73,225 shares Expires 2036-02-18 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC |
Davis J. E.Director · CEO and President
|
Tax withholdingCommon Stock | 3,788 | $206.99 | $784,078.12 |
DisclosureSEC source: 0001599837-26-000002 · wk-form4_1771625504.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,153 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC |
Davis J. E.Director · CEO and President
|
Tax withholdingCommon Stock | 2,396 | $210.01 | $503,183.96 |
DisclosureSEC source: 0001599837-26-000002 · wk-form4_1771625504.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,941 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC |
Davis J. E.Director · CEO and President
|
GrantCommon Stock | 15,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001599837-26-000002 · wk-form4_1771625504.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,337 F1 · security: Represents an award of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC |
Doherty Catherine T.EVP, Regional Businesses
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 13,514 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · derivative · entry 6 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,514 Underlying: Common Stock · 13,514 shares Expires 2036-02-18 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC |
Doherty Catherine T.EVP, Regional Businesses
|
Tax withholdingCommon Stock | 728 | $206.99 | $150,688.72 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,835 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC |
Doherty Catherine T.EVP, Regional Businesses
|
Tax withholdingCommon Stock | 433 | $210.01 | $90,934.33 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,563 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC |
Doherty Catherine T.EVP, Regional Businesses
|
GrantCommon Stock | 2,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,996 F1 · security: Represents an award of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:09 UTC |
Deppe Michael JSVP, Corp. Controller & CAO
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 1,688 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · derivative · entry 5 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,688 Underlying: Common Stock · 1,688 shares Expires 2036-02-18 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:09 UTC |
Deppe Michael JSVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 99 | $206.99 | $20,492.01 |
DisclosureSEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · nonDerivative · entry 3 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,560 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:09 UTC |
Deppe Michael JSVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 83 | $210.01 | $17,430.83 |
DisclosureSEC source: 0001771759-26-000002 · wk-form4_1771625359.xml · nonDerivative · entry 2 Deppe Michael J · CIK 0001771759 · SVP, Corp. Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,659 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.